Ellenbecker Investment Group Abb Vie Inc. Transaction History

Ellenbecker Investment Group

$527 Million
Q3 2024

A detailed history of Ellenbecker Investment Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Ellenbecker Investment Group holds 5,386 shares of ABBV stock, worth $965,171. This represents 0.2% of its overall portfolio holdings.

Number of Shares

5,386

Previous 6,061 11.14%

Holding current value

$965,171

Previous $1.04 Million 2.31%

% of portfolio

0.2%

Previous 0.21%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$163.84 - $199.33 $110,592 - $134,547	-675 Reduced 11.14%	5,386 $1.06 Million
Q2 2024 Jul 11, 2024	BUY	$154.79 - $180.76 $12,692 - $14,822	82 Added 1.37%	6,061 $1.04 Million
Q1 2024 Apr 09, 2024	BUY	$159.82 - $182.1 $15,182 - $17,299	95 Added 1.61%	5,979 $1.09 Million
Q4 2023 Feb 01, 2024	BUY	$137.6 - $154.97 $21,052 - $23,710	153 Added 2.67%	5,884 $911,000
Q3 2023 Oct 17, 2023	SELL	$133.59 - $154.65 $9,618 - $11,134	-72 Reduced 1.24%	5,731 $854,000
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $10,998 - $13,686	83 Added 1.45%	5,803 $781,000
Q1 2023 Apr 18, 2023	BUY	$144.61 - $166.54 $6,073 - $6,994	42 Added 0.74%	5,720 $911,000
Q4 2022 Jan 11, 2023	BUY	$138.31 - $165.87 $99,306 - $119,094	718 Added 14.48%	5,678 $917,000
Q3 2022 Oct 17, 2022	BUY	$134.21 - $153.93 $38,384 - $44,023	286 Added 6.12%	4,960 $665,000
Q2 2022 Jul 05, 2022	BUY	$137.62 - $174.96 $18,165 - $23,094	132 Added 2.91%	4,674 $715,000
Q1 2022 Apr 13, 2022	BUY	$131.98 - $163.75 $4,355 - $5,403	33 Added 0.73%	4,542 $736,000
Q4 2021 Jan 04, 2022	BUY	$107.43 - $135.93 $4,834 - $6,116	45 Added 1.01%	4,509 $610,000
Q3 2021 Oct 20, 2021	SELL	$106.4 - $120.78 $3,724 - $4,227	-35 Reduced 0.78%	4,464 $481,000
Q2 2021 Jul 07, 2021	SELL	$105.21 - $117.21 $3,261 - $3,633	-31 Reduced 0.68%	4,499 $507,000
Q1 2021 Apr 06, 2021	BUY	$102.3 - $112.62 $9,513 - $10,473	93 Added 2.1%	4,530 $490,000
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $643 - $869	8 Added 0.18%	4,437 $475,000
Q3 2020 Oct 07, 2020	BUY	$85.91 - $100.83 $6,185 - $7,259	72 Added 1.65%	4,429 $388,000
Q2 2020 Jul 02, 2020	BUY	$73.37 - $98.18 $12,546 - $16,788	171 Added 4.09%	4,357 $428,000
Q1 2020 Apr 01, 2020	BUY	$64.5 - $97.79 $322 - $488	5 Added 0.12%	4,186 $319,000
Q4 2019 Jan 07, 2020	SELL	$72.13 - $90.25 $7,068 - $8,844	-98 Reduced 2.29%	4,181 $370,000
Q3 2019 Oct 09, 2019	BUY	$62.98 - $75.72 $17,823 - $21,428	283 Added 7.08%	4,279 $324,000
Q2 2019 Jul 05, 2019	BUY	$65.7 - $83.98 $22,863 - $29,225	348 Added 9.54%	3,996 $291,000
Q1 2019 Apr 04, 2019	BUY	$77.14 - $90.79 $18,745 - $22,061	243 Added 7.14%	3,648 $294,000
Q4 2018 Jan 02, 2019	BUY	$77.85 - $96.01 $265,079 - $326,914	3,405 New	3,405 $314,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellenbecker Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Ellenbecker Investment Group with notifications on news.

Account

Ellenbecker Investment Group Abb Vie Inc. Transaction History